Literature DB >> 6614390

Follow-up study of children with cerebral coordination disturbance (CCD, Vojta).

S Imamura, K Sakuma, T Takahashi.   

Abstract

713 children (from newborn to 12-month-old) with delayed motor development were carefully examined and classified into normal, very light cerebral coordination disturbance (CCD, Vojta), light CCD, moderate CCD, severe CCD, suspected cerebral palsy (CP) and other diseases at their first visit, and were followed up carefully. Finally, 89.0% of very light CCD, 71.4% of light CCD, 56.0% of moderate CCD and 30.0% of severe CCD developed into normal. 59.5% of moderate CCD and 45.5% of severe CCD among children who were given Vojta's physiotherapy developed into normal. The classification of cases with delayed motor development into very light, light, moderate and severe CCD based on the extent of abnormality in their postural reflexes is useful and well correlated with their prognosis. Treatment by Vojta's method seems to be efficient and helpful for young children with delayed motor development.

Entities:  

Mesh:

Year:  1983        PMID: 6614390     DOI: 10.1016/s0387-7604(83)80024-2

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  3 in total

Review 1.  VOJTA neurophysiologic therapy.

Authors:  H Bauer; G Appaji; D Mundt
Journal:  Indian J Pediatr       Date:  1992 Jan-Feb       Impact factor: 1.967

2.  Assessment of visual perception in adolescents with a history of central coordination disorder in early life - 15-year follow-up study.

Authors:  Wojciech Kiebzak; Ireneusz M Kowalski; Małgorzata Domagalska; Andrzej Szopa; Michał Dwornik; Jolanta Kujawa; Agnieszka Stępień; Zbigniew Sliwiński
Journal:  Arch Med Sci       Date:  2012-05-15       Impact factor: 3.318

3.  Marker-Based Movement Analysis of Human Body Parts in Therapeutic Procedure.

Authors:  Muhammad Hassan Khan; Martin Zöller; Muhammad Shahid Farid; Marcin Grzegorzek
Journal:  Sensors (Basel)       Date:  2020-06-10       Impact factor: 3.576

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.